SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems
PR Newswire —
BOSTON and ROLLE, Switzerland, Feb. 10, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced the addition of two of the largest U.S. healthcare systems to its network. The two new institutions, which collectively analyze...